MAD2L1 and cancer: In vitro we demonstrated that excess miR-493-3p impaired cancer cells’ normal response to taxol and nocodazole treatments and enabled them to evade SAC-dependent mitotic arrest and consequent apoptosis due to the reduced Mad2 protein.